What changed
2026-08-20 17:32 UTC → 2026-09-10 21:00 UTC ·
added
removed
Amil healthcare acquisition owner terminates sale negotiations
Investment funds Advent International and Bain Capital are in advanced negotiations to acquire Negotiations for the sale of 100% of the Brazilian healthcare operator Amil. Initial reports indicated the transaction could be valued Amil to US-based private equity firms Bain Capital and Advent International have concluded without a deal. Despite reaching an advanced stage where discussions centered on offers between R$ 10 16 billion and R$ 17 20 billion, with a primary point of contention being controlling owner José Seripieri Filho has decided to terminate the level of control sought by negotiations. This decision was communicated to Amil’s approximately 24,000 employees via an internal memo. While the funds versus process initially focused on selling a minority stake to inject capital, the willingness of current owner José scope eventually evolved into a potential full sale. However, reports indicate that Seripieri Júnior Filho remained committed to sell. As negotiations progressed, maintaining control of the operator and was hesitant to engage deeply in the transaction process. The negotiations, which were primarily led by Amil’s CFO Grace Tourinho, had previously been stalled by a valuation gap of approximately R$ 2 billion emerged. Seripieri is reportedly seeking a total deal value of around R$ 18 billion and the need to recalculate financial accounts to account for both the company purchase and the assumption of Amil’s existing financial obligations. While recent meetings between Seripieri and Amil currently holds the investment funds did not reach third position in Brazil’s supplementary health sector, serving 3.6 million beneficiaries and operating 46 hospitals. The company reports an immediate resolution due to the need for recalculated financial accounts, the firms have already identified Irlau Machado, former president annual revenue of NotreDame Intermédica, as R$ 44 billion and a potential candidate to lead the company following the acquisition. projected profit of R$ 2.6 billion for 2026.